Chondroitin sulfate proteoglycans impede myelination by oligodendrocytes after perinatal white matter injury

Experimental Neurology

Volumn 269, Issue , 2015, Pages 213-223

  Deng, Ying Ping ^a,b   Sun, Yi ^a   Hu, Lan ^a   Li, Zhi Hua ^a   Xu, Quan Mei ^b   Pei, Yi Ling ^c   Huang, Zhi Heng ^a,b   Yang, Zhen Gang ^c   Chen, Chao ^a,b  

^a CHILDREN S HOSPITAL OF FUDAN UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Chondroitin sulfate proteoglycan; Cognitive dysfunction; Hypomyelination; Hypoxia ischemia; Newborn; Rat

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; MYELIN BASIC PROTEIN; PROTEOCHONDROITIN SULFATE;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL MIGRATION; COGNITIVE DEFECT; COMMON CAROTID ARTERY; CONTROLLED STUDY; CORPUS CALLOSUM; ELECTRON MICROSCOPY; EXTERNAL CAPSULE; MORRIS WATER MAZE TEST; MYELINATION; NERVE SPROUTING; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; WHITE MATTER INJURY; ANIMAL; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INJURIES; METABOLISM; MYELIN SHEATH; NEWBORN; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; WHITE MATTER;

ANIMALS; ANIMALS, NEWBORN; CELL DIFFERENTIATION; CHONDROITIN SULFATE PROTEOGLYCANS; HYPOXIA-ISCHEMIA, BRAIN; MYELIN BASIC PROTEIN; MYELIN SHEATH; OLIGODENDROGLIA; RATS, SPRAGUE-DAWLEY; WHITE MATTER;

EID: 84928688067     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2015.03.026     Document Type: Article

References (48)

1. Aya-ay J., Mayer J., Eakin A.K., Muffly B.G., Anello M., Sandy J.D., Gottschall P.E. The effect of hypoxic-ischemic brain injury in perinatal rats on the abundance and proteolysis of brevican and NG2. Exp. Neurol. 2005, 193:149-162.
2. Back S.A., Han B.H., Luo N.L., Chricton C.A., Xanthoudakis S., Tam J., Arvin K.L., Holtzman D.M. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J. Neurosci. 2002, 22:455-463.
3. Back S.A., Luo N.L., Mallinson R.A., O'Malley J.P., Wallen L.D., Frei B., Morrow J.D., Petito C.K., Roberts C.T., Murdoch G.H., Montine T.J. Selective vulnerability of preterm white matter to oxidative damage defined by F2-isoprostanes. Ann. Neurol. 2005, 58:108-120.
4. Barritt A.W., Davies M., Marchand F., Hartley R., Grist J., Yip P., McMahon S.B., Bradbury E.J. Chondroitinase ABC promotes sprouting of intact and injured spinal systems after spinal cord injury. J. Neurosci. 2006, 26:10856-10867.
5. Bartus K., James N.D., Bosch K.D., Bradbury E.J. Chondroitin sulphate proteoglycans: key modulators of spinal cord and brain plasticity. Exp. Neurol. 2012, 235:5-17.
6. Billiards S.S., Haynes R.L., Folkerth R.D., Borenstein N.S., Trachtenberg F.L., Rowitch D.H., Ligon K.L., Volpe J.J., Kinney H.C. Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia. Brain Pathol. 2008, 18:153-163.
7. Cafferty W.B., Bradbury E.J., Lidierth M., Jones M., Duffy P.J., Pezet S., McMahon S.B. Chondroitinase ABC-mediated plasticity of spinal sensory function. J. Neurosci. 2008, 28:11998-12009.
8. Cengiz P., Uluc K., Kendigelen P., Akture E., Hutchinson E., Song C., Zhang L., Lee J., Budoff G.E., Meyerand E., Sun D., Ferrazzano P. Chronic neurological deficits in mice after perinatal hypoxia and ischemia correlate with hemispheric tissue loss and white matter injury detected by MRI. Dev. Neurosci. 2011, 33:270-279.
9. Chen X.R., Liao S.J., Ye L.X., Gong Q., Ding Q., Zeng J.S., Yu J. Neuroprotective effect of chondroitinase ABC on primary and secondary brain injury after stroke in hypertensive rats. Brain Res. 2014, 1543:324-333.
10. D'Hooge R., De Deyn P.P. Applications of the Morris water maze in the study of learning and memory. Brain Res. Rev. 2001, 36:60-90.
11. Harris N.G., Carmichael S.T., Hovda D.A., Sutton R.L. Traumatic brain injury results in disparate regions of chondroitin sulfate proteoglycan expression that are temporally limited. J. Neurosci. Res. 2009, 87:2937-2950.
12. Harris N.G., Nogueira M.S., Verley D.R., Sutton R.L. Chondroitinase enhances cortical map plasticity and increases functionally active sprouting axons after brain injury. J. Neurotrauma. 2013, 30:1257-1269.
13. Hensch T.K. Critical period regulation. Annu. Rev. Neurosci. 2004, 27:549-579.
14. Huang Z., Liu J., Cheung P.Y., Chen C. Long-term cognitive impairment and myelination deficiency in a rat model of perinatal hypoxic-ischemic brain injury. Brain Res. 2009, 1301:100-109.
15. Jefferson S.C., Tester N.J., Howland D.R. Chondroitinase ABC promotes recovery of adaptive limb movements and enhances axonal growth caudal to a spinal hemisection. J. Neurosci. 2011, 31:5710-5720.
16. Kaneko M., Kubo T., Hata K., Yamaguchi A., Yamashita T. Repulsion of cerebellar granule neurons by chondroitin sulfate proteoglycans is mediated by MAPK pathway. Neurosci. Lett. 2007, 423:62-67.
17. Lau L.W., Keough M.B., Haylock-Jacobs S., Cua R., Doring A., Sloka S., Stirling D.P., Rivest S., Yong V.W. Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination. Ann. Neurol. 2012, 72:419-432.
18. Leinster V.H., Joy M.T., Vuononvirta R.E., Bolsover S.R., Anderson P.N. ErbB1 epidermal growth factor receptor is a valid target for reducing the effects of multiple inhibitors of axonal regeneration. Exp. Neurol. 2013, 239:82-90.
19. Leonardo C.C., Eakin A.K., Ajmo J.M., Gottschall P.E. Versican and brevican are expressed with distinct pathology in neonatal hypoxic-ischemic injury. J. Neurosci. Res. 2008, 86:1106-1114.
20. Levine J.M., Reynolds R., Fawcett J.W. The oligodendrocyte precursor cell in health and disease. Trends Neurosci. 2001, 24:39-47.
21. Lin R., Kwok J.C., Crespo D., Fawcett J.W. Chondroitinase ABC has a long-lasting effect on chondroitin sulphate glycosaminoglycan content in the injured rat brain. J. Neurochem. 2008, 104:400-408.
22. Lingor P., Teusch N., Schwarz K., Mueller R., Mack H., Bahr M., Mueller B.K. Inhibition of Rho kinase (ROCK) increases neurite outgrowth on chondroitin sulphate proteoglycan in vitro and axonal regeneration in the adult optic nerve in vivo. J. Neurochem. 2007, 103:181-189.
23. Logitharajah P., Rutherford M.A., Cowan F.M. Hypoxic-ischemic encephalopathy in preterm infants: antecedent factors, brain imaging, and outcome. Pediatr. Res. 2009, 66:222-229.
24. Matsui F., Kakizawa H., Nishizuka M., Hirano K., Shuo T., Ida M., Tokita Y., Aono S., Keino H., Oohira A. Changes in the amounts of chondroitin sulfate proteoglycans in rat brain after neonatal hypoxia-ischemia. J. Neurosci. Res. 2005, 81:837-845.
25. McKeon R.J., Jurynec M.J., Buck C.R. The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar. J. Neurosci. 1999, 19:10778-10788.
26. Monnier P.P., Sierra A., Schwab J.M., Henke-Fahle S., Mueller B.K. The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar. Mol. Cell. Neurosci. 2003, 22:319-330.
27. Morgenstern D.A., Asher R.A., Fawcett J.W. Chondroitin sulphate proteoglycans in the CNS injury response. Prog. Brain Res. 2002, 137:313-332.
28. Myer D.J., Gurkoff G.G., Lee S.M., Hovda D.A., Sofroniew M.V. Essential protective roles of reactive astrocytes in traumatic brain injury. Brain 2006, 129:2761-2772.
29. Nilsson O.G., Shapiro M.L., Gage F.H., Olton D.S., Björklund A. Spatial learning and memory following fimbria-fornix transection and grafting of fetal septal neurons to the hippocampus. Exp. Brain Res. 1987, 67:195-215.
30. Pendleton J.C., Shamblott M.J., Gary D.S., Belegu V., Hurtado A., Malone M.L., McDonald J.W. Chondroitin sulfate proteoglycans inhibit oligodendrocyte myelination through PTPsigma. Exp. Neurol. 2013, 247:113-121.
31. Pogribna U., Yu X., Burson K., Zhou Y., Lasky R.E., Narayana P.A., Parikh N.A. Perinatal clinical antecedents of white matter microstructural abnormalities on diffusion tensor imaging in extremely preterm infants. PLoS ONE. 2013, 8. e72974.
32. Rauch U. Brain matrix: structure, turnover and necessity. Biochem. Soc. Trans. 2007, 35:656-660.
33. Redish A.D., Touretzky D.S. The role of the hippocampus in solving the Morris water maze. Neural Comput. 1998, 10:73-111.
34. Resch B., Neubauer K., Hofer N., Resch E., Maurer U., Haas J., Muller W. Episodes of hypocarbia and early-onset sepsis are risk factors for cystic periventricular leukomalacia in the preterm infant. Early Hum. Dev. 2012, 88:27-31.
35. Rolls A., Shechter R., Schwartz M. The bright side of the glial scar in CNS repair. Nat. Rev. Neurosci. 2009, 10:235-241.
36. Segovia K.N., McClure M., Moravec M., Luo N.L., Wan Y., Gong X., Riddle A., Craig A., Struve J., Sherman L.S., Back S.A. Arrested oligodendrocyte lineage maturation in chronic perinatal white matter injury. Ann. Neurol. 2008, 63:520-530.
37. Sherman L.S., Back S.A. A 'GAG' reflex prevents repair of the damaged CNS. Trends Neurosci. 2008, 31:44-52.
38. Siebert J.R., Osterhout D.J. The inhibitory effects of chondroitin sulfate proteoglycans on oligodendrocytes. J. Neurochem. 2011, 119:176-188.
39. Siebert J.R., Stelzner D.J., Osterhout D.J. Chondroitinase treatment following spinal contusion injury increases migration of oligodendrocyte progenitor cells. Exp. Neurol. 2011, 231:19-29.
40. Sofroniew M.V., Vinters H.V. Astrocytes: biology and pathology. Acta Neuropathol. 2010, 119:7-35.
41. Starkey M.L., Bartus K., Barritt A.W., Bradbury E.J. Chondroitinase ABC promotes compensatory sprouting of the intact corticospinal tract and recovery of forelimb function following unilateral pyramidotomy in adult mice. Eur. J. Neurosci. 2012, 36:3665-3678.
42. Suzuki S., Saito H., Yamagata T., Anno K., Seno N., Kawai Y., Furuhashi T. Formation of three types of disulfated disaccharides from chondroitin sulfates by chondroitinase digestion. J. Biol. Chem. 1968, 243:1543-1550.
43. Tang X., Davies J.E., Davies S.J. Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue. J. Neurosci. Res. 2003, 71:427-444.
44. Vannucci R.C., Connor J.R., Mauger D.T., Palmer C., Smith M.B., Towfighi J., Vannucci S.J. Rat model of perinatal hypoxic-ischemic brain damage. J. Neurosci. Res. 1999, 55:158-163.
45. Vorhees C.V., Williams M.T. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat. Protoc. 2006, 1:848-858.
46. Yamagata T., Saito H., Habuchi O., Suzuki S. Purification and properties of bacterial chondroitinases and chondrosulfatases. J. Biol. Chem. 1968, 243:1523-1535.
47. Yamaguchi Y. Lecticans: organizers of the brain extracellular matrix. Cell. Mol. Life Sci. 2000, 57:276-289.
48. Zaidi A.U., Bessert D.A., Ong J.E., Xu H., Barks J.D., Silverstein F.S., Skoff R.P. New oligodendrocytes are generated after neonatal hypoxic-ischemic brain injury in rodents. Glia. 2004, 46:380-390.